Advertisement
Opthea Limited

Opthea Limited Fundamental Analysis

OPT.AXASX
HealthcareBiotechnology
$0.60
$0.00(0.00%)
Australian Market opens in 48h 46m
Advertisement

Opthea Limited Fundamental Analysis

Opthea Limited (OPT.AX) shows weak financial fundamentals with a PE ratio of 2.87, profit margin of -1288.71%, and ROE of -3.12%. The company generates $-0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Operating Margin146.57%
PEG Ratio0.01
Current Ratio19.52

Areas of Concern

ROE-3.12%
Cash Position2.77%
We analyze OPT.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -121169.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-121169.3/100

We analyze OPT.AX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

OPT.AX demonstrates superior asset utilization.

ROA > 10%
11.69%

Valuation Score

Excellent

OPT.AX trades at attractive valuation levels.

PE < 25
2.87
PEG Ratio < 2
0.01

Growth Score

Moderate

OPT.AX shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

OPT.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
19.52

Profitability Score

Weak

OPT.AX struggles to sustain strong margins.

ROE > 15%
-312.02%
Net Margin ≥ 15%
-1288.71%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPT.AX Expensive or Cheap?

P/E Ratio

OPT.AX trades at 2.87 times earnings. This suggests potential undervaluation.

2.87

PEG Ratio

When adjusting for growth, OPT.AX's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values Opthea Limited at 24.64 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

24.64

EV/EBITDA

Enterprise value stands at -7.93 times EBITDA. This is generally considered low.

-7.93

How Well Does OPT.AX Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $-1288.71 as profit after all expenses.

-1288.71%

Operating Margin

Core operations generate 146.57 in profit for every $100 in revenue, before interest and taxes.

146.57%

ROE

Management delivers $-3.12 in profit for every $100 of shareholder equity.

-3.12%

ROA

Opthea Limited generates $11.69 in profit for every $100 in assets, demonstrating efficient asset deployment.

11.69%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates strong operating cash flow of $-126.35M, reflecting robust business health.

$-126.35M

Free Cash Flow

Opthea Limited generates strong free cash flow of $-123.64M, providing ample flexibility for dividends, buybacks, or growth.

$-123.64M

FCF Per Share

Each share generates $-0.09 in free cash annually.

$-0.09

FCF Yield

OPT.AX converts -21.15% of its market value into free cash.

-21.15%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

2.87

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

24.64

vs 25 benchmark

P/S Ratio

Price to sales ratio

-2647.74

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

19.52

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.12

vs 25 benchmark

ROA

Return on assets percentage

11.69

vs 25 benchmark

ROCE

Return on capital employed

-1.40

vs 25 benchmark

How OPT.AX Stacks Against Its Sector Peers

MetricOPT.AX ValueSector AveragePerformance
P/E Ratio2.8730.23 Better (Cheaper)
ROE-312.02%403.00% Weak
Net Margin-128871.09%-11442.00% (disorted) Weak
Debt/Equity0.000.78 Strong (Low Leverage)
Current Ratio19.524.98 Strong Liquidity
ROA1168.69%-248.00% (disorted) Strong

OPT.AX outperforms its industry in 4 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ